Search

Your search keyword '"Bernabucci, Veronica"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Bernabucci, Veronica" Remove constraint Author: "Bernabucci, Veronica"
49 results on '"Bernabucci, Veronica"'

Search Results

1. Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy

2. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

3. Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19

4. Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV

5. Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

6. AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF)

7. Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis

12. Peptic Ulcer and Helicobacter Pylori

14. Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

15. Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV

16. Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals

17. Corrigendum to 'Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV' [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019)

18. Liver Angiopoietin‐2 Is a Key Predictor of D e N ovo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct‐Acting Antivirals

19. Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41]

20. Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis

22. Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV

23. Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network

24. Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

25. Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: A real-life strategy

26. Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network

27. Liver Angiopoietin‐2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct‐Acting Antivirals.

28. Effetti avversi gastrointestinali: farmaci anti-infiammatori non steroidei ed Helicobacter pylori

29. Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: a real-life strategy.

30. Diagnosi non invasiva e terapia per Helicobacter Pylori

31. Nuove terapie per curare l’infezione da Helicobacter pylori

32. Epidemiologia dell’Infezione da Helicobacter pylori e Cancro gastrico non cardiale. Insegnamenti per il futuro

34. E-test for Metronidazole Susceptibility Q1 in H pylori: Use of the Wrong Standard May Have Led to the Wrong Conclusion: Reply

38. Sex, liver desease, and response to antiviral therapy

39. Reproductive Status Is Associated with the Severity of Fibrosis in Women with Hepatitis C

42. Peptic ulcer andHelicobacter pylori

43. Serological Markers for Gastric Atrophy in Asymptomatic Patients Infected withHelicobacter pylori.

44. Corrigendum to 'Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV' [J Hepatol 68 (2018) 33-41]

45. Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis

46. Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network

47. AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF)

48. Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV.

49. [Non-invasive analyses for the diagnosis of Helicobacter pylori infection. A critical review of the literature].

Catalog

Books, media, physical & digital resources